Stryker

Historical price data

Stryker Corporation's mission is to make healthcare better by providing innovative products and services that improve patient and hospital outcomes. The company has achieved this through strategic diversification across high-growth medical device segments, including its flagship Mako robotic-assisted surgery platform, and consistent execution of a disciplined acquisition strategy to bolster its technology portfolio. Its core strategy revolves around deep clinical integration, global market penetration, and sustained R&D investment to drive procedural efficiency and value-based care. With a market capitalization exceeding $126 billion, Stryker is a financially robust leader poised to capitalize on aging demographics and technological adoption in surgery.

A multi-faceted innovation engine integrating robotics (Mako), advanced surgical navigation, 3D imaging, additive manufacturing for implants, and digital data ecosystems to enhance surgical precision, efficiency, and patient outcomes.

Stryker competes with giants like Johnson & Johnson and Medtronic across orthopedics, spine, and neurotechnology, and with numerous players in MedSurg. Its competitive edge is built on the first-mover advantage of its Mako robotics platform, a highly diversified portfolio that mitigates segment risk, and a proven track record of strategic acquisitions that bolster its technology moat.